How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework

Human life is deeply influenced by infectious diseases. A vaccine, when available, is one of the most effective ways of controlling the spread of an epidemic. However, vaccine shortage and uncertain vaccine effectiveness in the early stage of vaccine production make vaccine allocation a critical iss...

Full description

Bibliographic Details
Main Authors: Hao Wu, Kaibo Wang, Lei Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.934891/full
_version_ 1798036843601592320
author Hao Wu
Kaibo Wang
Lei Xu
author_facet Hao Wu
Kaibo Wang
Lei Xu
author_sort Hao Wu
collection DOAJ
description Human life is deeply influenced by infectious diseases. A vaccine, when available, is one of the most effective ways of controlling the spread of an epidemic. However, vaccine shortage and uncertain vaccine effectiveness in the early stage of vaccine production make vaccine allocation a critical issue. To tackle this issue, we propose a multi-objective framework to optimize the vaccine allocation strategy among different age groups during an epidemic under vaccine shortage in this study. Minimizing total disease onsets and total severe cases are the two objectives of this vaccine allocation optimization problem, and the multistage feature of vaccine allocation are considered in the framework. An improved Strength Pareto Evolutionary Algorithm (SPEA2) is used to solve the optimization problem. To evaluate the two objectives under different strategies, a deterministic age-stratified extended SEIR model is developed. In the proposed framework, different combinations of vaccine effectiveness and vaccine production capacity are investigated, and it is identified that for COVID-19 the optimal strategy is highly related to vaccine-related parameters. When the vaccine effectiveness is low, allocating most of vaccines to 0–19 age group or 65+ age group is a better choice under a low production capacity, while allocating most of vaccines to 20–49 age group or 50–64 age group is a better choice under a relatively high production capacity. When the vaccine effectiveness is high, a better strategy is to allocate vaccines to 65+ age group under a low production capacity, while to allocate vaccines to 20–49 age group under a relatively high production capacity.
first_indexed 2024-04-11T21:18:33Z
format Article
id doaj.art-4a90aafe711e4857a9ea4a2808e3947b
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-11T21:18:33Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-4a90aafe711e4857a9ea4a2808e3947b2022-12-22T04:02:43ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-09-011010.3389/fpubh.2022.934891934891How can age-based vaccine allocation strategies be optimized? A multi-objective optimization frameworkHao Wu0Kaibo Wang1Lei Xu2Department of Industrial Engineering, Tsinghua University, Beijing, ChinaVanke School of Public Health, Tsinghua University, Beijing, ChinaVanke School of Public Health, Tsinghua University, Beijing, ChinaHuman life is deeply influenced by infectious diseases. A vaccine, when available, is one of the most effective ways of controlling the spread of an epidemic. However, vaccine shortage and uncertain vaccine effectiveness in the early stage of vaccine production make vaccine allocation a critical issue. To tackle this issue, we propose a multi-objective framework to optimize the vaccine allocation strategy among different age groups during an epidemic under vaccine shortage in this study. Minimizing total disease onsets and total severe cases are the two objectives of this vaccine allocation optimization problem, and the multistage feature of vaccine allocation are considered in the framework. An improved Strength Pareto Evolutionary Algorithm (SPEA2) is used to solve the optimization problem. To evaluate the two objectives under different strategies, a deterministic age-stratified extended SEIR model is developed. In the proposed framework, different combinations of vaccine effectiveness and vaccine production capacity are investigated, and it is identified that for COVID-19 the optimal strategy is highly related to vaccine-related parameters. When the vaccine effectiveness is low, allocating most of vaccines to 0–19 age group or 65+ age group is a better choice under a low production capacity, while allocating most of vaccines to 20–49 age group or 50–64 age group is a better choice under a relatively high production capacity. When the vaccine effectiveness is high, a better strategy is to allocate vaccines to 65+ age group under a low production capacity, while to allocate vaccines to 20–49 age group under a relatively high production capacity.https://www.frontiersin.org/articles/10.3389/fpubh.2022.934891/fullinfectious diseaseSEIR modelmulti-objective (MO) optimizationvaccine allocationimproved Strength Pareto Evolutionary Algorithm (SPEA2)
spellingShingle Hao Wu
Kaibo Wang
Lei Xu
How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework
Frontiers in Public Health
infectious disease
SEIR model
multi-objective (MO) optimization
vaccine allocation
improved Strength Pareto Evolutionary Algorithm (SPEA2)
title How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework
title_full How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework
title_fullStr How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework
title_full_unstemmed How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework
title_short How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework
title_sort how can age based vaccine allocation strategies be optimized a multi objective optimization framework
topic infectious disease
SEIR model
multi-objective (MO) optimization
vaccine allocation
improved Strength Pareto Evolutionary Algorithm (SPEA2)
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.934891/full
work_keys_str_mv AT haowu howcanagebasedvaccineallocationstrategiesbeoptimizedamultiobjectiveoptimizationframework
AT kaibowang howcanagebasedvaccineallocationstrategiesbeoptimizedamultiobjectiveoptimizationframework
AT leixu howcanagebasedvaccineallocationstrategiesbeoptimizedamultiobjectiveoptimizationframework